GALECTIN THERAPEUTIC | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (43)

Latest Posts

About This Stock More About This Stock
More Personal Portfolio: Biotech, Commodities, And Gold
Article By: John Mauldin
Sunday, September 24, 2023 4:50 AM EDT
In a few years we will know if that was an extraordinarily opportunistic moment, or a long and frustrating rabbit hole.
In this article: URA, GALT, GLD, MYMD
Read
Wall Street Rally Builds, Weekly Wins In Sight
Article By: Schaeffers Research
Friday, July 9, 2021 12:31 PM EDT
The Dow Jones Industrial Average is 400 points higher at midday, extending this morning's gains as Wall Street, at least for a day, moves past fears of slowing economic growth.
In this article: GALT, CARV, NDX, SPX, VIX, DJI, SGTX
Read
Conatus Pharmaceuticals Up On Novartis Partnership But Run Might Be Just Beginning
Article By: Terry Chrisomalis
Tuesday, January 24, 2017 8:37 AM EDT
Conatus has one major milestone in place for 2017 that could bring a substantial gain. This milestone is Novartis taking the option to license Emricasan.
In this article: CNAT Also: NVS, GALT, ICPT, GNFTF
Read
With $50M Purchase Of Akarna, Allergan Buys Two Liver Researchers In 24 Hours
Article By: The Fly
Tuesday, September 20, 2016 9:35 PM EDT
Shares of Allergan are in focus after the pharmaceutical giant announced the acquisition of Akarna after the closing bell, marking its second M&A announcement today after this morning's deal for Tobira Therapeutics.
In this article: AGN, TBRA Also: GALT, ICPT, CNAT
Read
Synta Pharmaceuticals Merges With Privately Held Madrigal
Article By: Terry Chrisomalis
Thursday, April 14, 2016 10:34 PM EDT
Madrigal will own 64% of the combined company; the deal should finalize in Q3.
In this article: SNTA Also: GILD, ICPT, GALT, GLMD, CNAT
Read

Latest Tweets for $GALT

No tweets yet!

PARTNER HEADLINES